Literature DB >> 8156277

Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease.

W L Beatty1, G I Byrne, R P Morrison.   

Abstract

Chlamydia trachomatis is an important human pathogen that mediates disease processes capable of inflicting permanent damage. Aggressive inflammatory responses to repeated infections, and to a persistent form of this intracellular bacterium, are thought to initiate the pathogenic events that lead to the debilitating sequelae of blinding trachoma and infertility.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8156277     DOI: 10.1016/0966-842x(94)90542-8

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  58 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Chlamydial colonization of multiple mucosae following infection by any mucosal route.

Authors:  L L Perry; S Hughes
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  Chlamydial GroEL autoregulates its own expression through direct interactions with the HrcA repressor protein.

Authors:  Adam C Wilson; Christine C Wu; John R Yates; Ming Tan
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

Review 4.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

5.  Evaluation of patients with dry eye disease for conjunctival Chlamydia trachomatis and Ureaplasma urealyticum.

Authors:  Maha Mohssen Abdelfattah; Rania Abdelmonem Khattab; Magda H Mahran; Ebrahim S Elborgy
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

6.  Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae.

Authors:  Catarina V Nogueira; Xuqing Zhang; Nicholas Giovannone; Erica L Sennott; Michael N Starnbach
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

7.  Prevention of coronary heart disease through treatment of infection with Chlamydia pneumoniae? Estimation of possible effectiveness and costs.

Authors:  C Sanderson; M Kubin
Journal:  Health Care Manag Sci       Date:  2001-12

Review 8.  Concurrent gonococcal and chlamydial infection: how best to treat.

Authors:  A J Robinson; G L Ridgway
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 9.  Killing me softly: chlamydial use of proteolysis for evading host defenses.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2009-09-16       Impact factor: 17.079

10.  Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis.

Authors:  D Kesley Robertson; Ling Gu; Regina K Rowe; Wandy L Beatty
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.